-
Abstract Number: LB/CO01.1
A Novel Adeno Associated Virus (AAV) Gene Therapy (FLT180a) Achieves Normal FIX Activity Levels in Severe Hemophilia B (HB) Patients (B-AMAZE Study)
-
Abstract Number: LB/CO01.2
Thrombosis, Bleeding, and the Effect of Anticoagulation on Survival in Critically Ill Patients with COVID-19 in the United States
-
Abstract Number: LB/CO01.3
Incidence of Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalisation
-
Abstract Number: LB/CO01.4
Higher Incidence of Thrombotic Complications in Hospitalized Patients with SARS-COV-2 Virus versus Influenza Virus Infections
-
Abstract Number: OC 01.1
von Willebrand Factor as a Predictor of Mortality and its Target Concentration Dependent Inhibition by BT200 Aptamer in Patients Treated with Potent ADP Receptor Blockers
-
Abstract Number: OC 01.2
Low-grade Endotoxaemia Enhances Artery Thrombus Growth via Toll-like Receptor 4: Implication for Myocardial Infarction
-
Abstract Number: OC 01.3
Unraveling the Protective Effects of Factor Xa Inhibition by Rivaroxaban on Atherosclerosis by RNA Sequencing
-
Abstract Number: OC 01.4
Reduction of Intracellular Sodium Protects from Inflammation and Atherosclerotic Plaque Progression
-
Abstract Number: OC 01.5
Impact of Platelet-Selective TGF-β1-Deficiency in Atherogenesis and CD4+ T Effector Responses Using a No-Germline Genetic Engineering Atherosclerosis Mouse Model
-
Abstract Number: OC 02.1
Fibrin γ-chain Crosslinking Plays an Important Role in Preventing Thrombus Breakdown and Embolisation in-vivo
-
Abstract Number: OC 02.2
Chemical Modulation of Fibrinogen Production and its Impact on Venous Thrombosis
-
Abstract Number: OC 02.3
FXIII Catalyses Histone-Fibrin Crosslinking to Inhibit Fibrinolysis
-
Abstract Number: OC 02.4
Fibrinogen Is Citrullinated in Venous Thrombi and Forms Fragile Clots with Increased Resistance to Lysis
-
Abstract Number: OC 02.5
Low α2-plasmin Inhibitor Antigen Levels on Admission Predict Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
-
Abstract Number: OC 03.1
Immune Profiling of Previously Untreated Patients with Severe Haemophilia A by High-throughput Mimotope Variation Analysis
-
Abstract Number: OC 03.2
Final Results of PUPs A-LONG Study: Evaluating Safety and Efficacy of rFVIIIFc in Previously Untreated Patients with Haemophilia A
-
Abstract Number: OC 03.3
Deciphering the Ets-1/2-mediated Transcriptional Regulation of F8 Gene Identifies a Minimal F8 Promoter for Hemophilia A Gene Therapy
-
Abstract Number: OC 03.4
First In Human Liver Biopsy Study Following Gene Therapy for Hemophilia A
-
Abstract Number: OC 03.5
Phase I/II Trial of SPK-8011: Stable and Durable FVIII Expression for >2 Years with Significant ABR Improvements in Initial Dose Cohorts Following AAV-Mediated FVIII Gene Transfer for Hemophilia A
-
Abstract Number: OC 04.1
Moderate Platelet Defects but Efficiently Restored Thrombopoietin Production Early after Partial Hepatectomy via JAK2-STAT3 Signaling in Mice
- 1
- 2
- 3
- …
- 120
- Next Page »